As of 2024-12-15, the Relative Valuation of Cell Impact AB (publ) (CI.ST) is (3.56) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 0.16 SEK, the upside of Cell Impact AB (publ) based on Relative Valuation is -2286.7%.
The range of the Relative Valuation is (3.36) - (3.59) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.9x - 27.4x | 24.8x |
| Forward P/E multiples | 20.0x - 23.4x | 21.7x |
| Fair Price | (3.36) - (3.59) | (3.56) |
| Upside | -2165.7% - -2305.0% | -2286.7% |
| Date | P/E |
| 2024-12-11 | -1.13 |
| 2024-12-10 | -1.17 |
| 2024-12-09 | -1.16 |
| 2024-12-06 | -1.15 |
| 2024-12-05 | -1.13 |
| 2024-12-04 | -1.13 |
| 2024-12-03 | -1.12 |
| 2024-12-02 | -1.12 |
| 2024-11-29 | -1.12 |
| 2024-11-28 | -1.13 |
| 2024-11-27 | -1.13 |
| 2024-11-26 | -1.17 |
| 2024-11-25 | -1.19 |
| 2024-11-22 | -1.17 |
| 2024-11-21 | -1.14 |
| 2024-11-20 | -1.17 |
| 2024-11-19 | -1.15 |
| 2024-11-18 | -1.14 |
| 2024-11-15 | -1.19 |
| 2024-11-14 | -1.17 |
| 2024-11-13 | -1.11 |
| 2024-11-12 | -1.16 |
| 2024-11-11 | -1.13 |
| 2024-11-08 | -1.23 |
| 2024-11-07 | -1.25 |
| 2024-11-06 | -1.25 |
| 2024-11-05 | -1.30 |
| 2024-11-04 | -1.31 |
| 2024-11-01 | -1.31 |
| 2024-10-31 | -1.34 |
| 2024-10-30 | -1.34 |
| 2024-10-29 | -1.40 |
| 2024-10-28 | -1.40 |
| 2024-10-25 | -1.37 |
| 2024-10-24 | -1.37 |
| 2024-10-23 | -1.44 |
| 2024-10-22 | -1.47 |
| 2024-10-21 | -1.33 |
| 2024-10-18 | -1.36 |
| 2024-10-17 | -1.34 |
| 2024-10-16 | -1.36 |
| 2024-10-15 | -1.43 |
| 2024-10-14 | -1.43 |
| 2024-10-11 | -1.45 |
| 2024-10-10 | -1.40 |
| 2024-10-09 | -1.42 |
| 2024-10-08 | -1.52 |
| 2024-10-07 | -1.60 |
| 2024-10-04 | -1.70 |
| 2024-10-03 | -1.76 |